Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_assertion type Assertion NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_head.
- NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_assertion description "[2-phenylimidazo[2,1-b]benzothiazole derivatives have been highlighted for their properties of targeting oncogenic Met receptor tyrosine kinase (RTK) signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_provenance.
- NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_assertion evidence source_evidence_literature NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_provenance.
- NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_assertion SIO_000772 23071625 NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_provenance.
- NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_assertion wasDerivedFrom befree-20150227 NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_provenance.
- NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_assertion wasGeneratedBy ECO_0000203 NP554417.RAb8neFx4UDmDKqUWhxa_grcptt5WHC1XlDRT54ZFx6ek130_provenance.